Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pease

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Global Spine Journal|January 24, 2024
The Utility of the Validated Intraoperative Bleeding Scale in Thoracolumbar Spine Surgery: A Single-Center Prospective StudyRyan A Smith, Tyler J Pease, Anthony K Chiu, et al.
World Neurosurgery|November 26, 2023
Lower Extremity Somatosensory Evoked Potentials Predict Functional Outcomes in Complete Traumatic Cervical Spinal Cord InjuryAnthony K Chiu, Sabrina P Bustos, Ovais Hasan, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Thienopyridine urea inhibitors of KDR kinaseH Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesKeith B Glaser, Junling Li, Patrick A Marcotte, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
Molecular Cancer Therapeutics|May 2, 2006
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitorDaniel H Albert, Paul Tapang, Terrance J Magoc, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Global Spine Journal|January 24, 2024
The Utility of the Validated Intraoperative Bleeding Scale in Thoracolumbar Spine Surgery: A Single-Center Prospective StudyRyan A Smith, Tyler J Pease, Anthony K Chiu, et al.
World Neurosurgery|November 26, 2023
Lower Extremity Somatosensory Evoked Potentials Predict Functional Outcomes in Complete Traumatic Cervical Spinal Cord InjuryAnthony K Chiu, Sabrina P Bustos, Ovais Hasan, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Thienopyridine urea inhibitors of KDR kinaseH Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesKeith B Glaser, Junling Li, Patrick A Marcotte, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
Molecular Cancer Therapeutics|May 2, 2006
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitorDaniel H Albert, Paul Tapang, Terrance J Magoc, et al.
Pageof 12